Craanen M E, Dekker W, Ferwerda J, Blok P, Tytgat G N
Department of Internal Medicine, St Elisabeth's of Groote Gasthuis, Haarlem, The Netherlands.
J Clin Gastroenterol. 1991 Jun;13(3):274-83. doi: 10.1097/00004836-199106000-00006.
We report our experience, between 1973 and 1989 of 302 patients with gastric cancer in a Dutch general hospital. In 144 (47.7%) of them gastric resection was performed. Twenty-eight patients had early gastric cancer (EGC) (9.3% of the entire series and 19.4% of the resected specimens). Multicentricity of EGC was noted in 3 patients (10.7%). The incidence of EGC decreased slightly during consecutive 8-year intervals. There were 16 men and 12 women (mean age 64 and 66 years, respectively). Standard biphasic contrast radiographic studies of the upper gastrointestinal tract diagnosed or suggested malignancy in all but one patient. Endoscopy with directed biopsy diagnosed malignancy in all patients. Twenty-one lesions (67.7%) were localized to the antral region. Type IIc was most frequent (38.7%). There were 21 intestinal-type and 10 diffuse-type EGC by the Lauren classification. The incidence of intestinal-type EGC decreased during two consecutive 8-year periods. All type I and IIa lesions were of the intestinal type, whereas all diffuse-type EGCs were either type IIc or III. Lymph node metastasis was observed in 9.7% of the lesions. The incidence of lymph node metastasis increased from 0% in mucosal cancer to 20% in submucosal cancer. The overall 5-year survival rate was 91.3%: (diffuse type 100% and intestinal type 85.7%). The 5-year survival rate was 100% in mucosal cancer and 81.8% in submucosal cancer.
我们报告了1973年至1989年期间在一家荷兰综合医院对302例胃癌患者的治疗经验。其中144例(47.7%)接受了胃切除术。28例患者患有早期胃癌(EGC)(占整个系列的9.3%,占切除标本的19.4%)。3例患者(10.7%)发现EGC为多中心性。在连续的8年间隔期内,EGC的发病率略有下降。患者中有16名男性和12名女性(平均年龄分别为64岁和66岁)。除1例患者外,所有患者均通过上消化道标准双相对比造影检查诊断或提示为恶性肿瘤。所有患者均通过内镜直视活检诊断为恶性肿瘤。21个病灶(67.7%)局限于胃窦区域。IIc型最为常见(38.7%)。根据劳伦分类法,有21例肠型EGC和10例弥漫型EGC。在连续两个8年期间,肠型EGC的发病率下降。所有I型和IIa型病灶均为肠型,而所有弥漫型EGC均为IIc型或III型。9.7%的病灶观察到有淋巴结转移。淋巴结转移的发生率从黏膜癌的0%增加到黏膜下癌的20%。总体5年生存率为91.3%:(弥漫型为100%,肠型为85.7%)。黏膜癌的5年生存率为100%,黏膜下癌的5年生存率为81.8%。